Assessment of immune response to SARS-CoV-2 with fully automated MAGLUMI 2019-nCoV IgG and IgM chemiluminescence immunoassays
暂无分享,去创建一个
G. Lippi | G. Salvagno | V. Militello | C. Bovo | A. Bassi | S. Gaino | G. Lo Cascio | M. Pegoraro | Cecilia Caloi | Angelo Peretti
[1] Mario Plebani,et al. Analytical performances of a chemiluminescence immunoassay for SARS-CoV-2 IgM/IgG and antibody kinetics , 2020, Clinical chemistry and laboratory medicine.
[2] A. Xu,et al. Diagnostic value and dynamic variance of serum antibody in coronavirus disease 2019 , 2020, International Journal of Infectious Diseases.
[3] A. Petherick. Developing antibody tests for SARS-CoV-2 , 2020, The Lancet.
[4] Giuseppe Lippi,et al. Coronavirus disease 2019 (COVID-19): the portrait of a perfect storm , 2020, Annals of translational medicine.
[5] Y. Yazdanpanah,et al. SARS-CoV-2 specific antibody responses in COVID-19 patients , 2020, medRxiv.
[6] G. Lippi,et al. The critical role of laboratory medicine during coronavirus disease 2019 (COVID-19) and other viral outbreaks , 2020, Clinical chemistry and laboratory medicine.
[7] Lei Liu,et al. Antibody responses to SARS-CoV-2 in patients of novel coronavirus disease 2019 , 2020, medRxiv.
[8] A. Šimundić,et al. Joint EFLM-COLABIOCLI Recommendation for venous blood sampling , 2018, Clinical chemistry and laboratory medicine.